Our extensive global reach can help you with your clinical trial needs. We have a strategic partnership with ACE Research, a Pan-Africa CRO operating across Africa and parts of Southeast Asia. Specifically, our expertise in more than 20 African countries with specialties in infectious diseases, sickle-cell anemia, and oncology has led to our serving approximately 10,000 subjects in Phase I-IV clinical trials.
More than 20 years ago, we began working with the US Army in Kenya to aid in development of treatments and preventions for malaria. Building on that platform, we continue to participate in clinical trial operations, and training to support disease surveillance, for the US government, NGOs, and Biopharma.
With offices in key locations in West Africa, and our network of accredited laboratories, clinical research sites and strategic partners throughout Sub-Saharan Africa, ICON can provide staff on the ground, providing rapid site selection, initiation, and staff training and patient enrolment in a total of 24 African countries.
Ebola virus disease
Our longstanding relationships within sub-Saharan Africa uniquely positioned us to be among the only CRO service providers on the ground in the 2014 Ebola hot zone. Our work related to Ebola Virus Disease (EVD) continues with longitudinal studies of EVD survivors and their communities.
- 24 African countries
- 10,000+ patients
- 20 + years’ experience in Africa